Sanofi (France)
NEWS
The two companies will seek approval for the biologic as a treatment for severe atopic dermatitis in children ages six to 11.
There were a number of major companies reporting their second-quarter financials for the year. Here’s a look at five of the bigger announcements this week.
Sanofi reported overall net sales increased by 5.5% for the second quarter, driven by Sanofi Genzyme, Sanofi Pasteur and emerging markets.
Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.
The introduction of EHLs allowed hemophilia patients to live a life beyond their disease, with improved quality of life, the study showed.
Clinical data showed Dupixent reduces nasal polyp size, improves congestion and loss of smell, while reducing the need for surgery and systemic corticosteroids.
July looks to be a quiet month for the U.S. Food and Drug Administration (FDA), and it sure looks like the agency is trying to get a lot of work done before the July 4 holiday. Here’s a look at the many approvals scheduled for this week.
The intention is to focus its research efforts on cancer, immunology, rare diseases and vaccines. The changes will result in the loss of 466 jobs in the two countries.
Google and Sanofi are partnering to set up a new virtual innovation lab with a focus on data technologies and digital health. The goal is to change how Sanofi develops new drugs.
JOBS
IN THE PRESS